Quote | Prelude Therapeutics Incorporated (NASDAQ:PRLD)
Last: | $3.62 |
---|---|
Change Percent: | 0.0% |
Open: | $3.7 |
Close: | $3.62 |
High: | $3.7 |
Low: | $3.58 |
Volume: | 10,000 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Prelude Therapeutics Incorporated (NASDAQ:PRLD)
2024-06-20 14:45:15 ET More on Prelude Therapeutics Seeking Alpha’s Quant Rating on Prelude Therapeutics Historical earnings data for Prelude Therapeutics Financial information for Prelude Therapeutics Read the full article on Seeking Alpha For...
2024-06-20 07:00:07 ET Peter Lawson from Barclays issued a price target of $3.00 for PRLD on 2024-06-20 05:33:00. The adjusted price target was set to $3.00. At the time of the announcement, PRLD was trading at $3.87. The overall price target consensus is at $10.67 with ...
Message Board Posts | Prelude Therapeutics Incorporated (NASDAQ:PRLD)
Subject | By | Source | When |
---|---|---|---|
$PRLD just the news we needed | Termite7 | investorshub | 04/25/2023 2:00:41 AM |
Do we have a winner?Turn around time? | Termite7 | investorshub | 04/24/2023 9:58:06 AM |
$PRLD where is the squeeze? | Termite7 | investorshub | 04/19/2023 8:50:44 AM |
$PRLD The gaining | Termite7 | investorshub | 04/18/2023 2:07:54 AM |
YES!!!!! .....GET 'EM!!!!!!! | Termite7 | investorshub | 10/07/2021 2:44:44 PM |
News, Short Squeeze, Breakout and More Instantly...
Prelude Therapeutics Incorporated Company Name:
PRLD Stock Symbol:
NASDAQ Market:
Prelude Therapeutics Incorporated Website:
2024-06-20 07:00:07 ET Peter Lawson from Barclays issued a price target of $3.00 for PRLD on 2024-06-20 05:33:00. The adjusted price target was set to $3.00. At the time of the announcement, PRLD was trading at $3.87. The overall price target consensus is at $10.67 with ...
WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June. Jefferies Global Healthcare Conference 2...
WILMINGTON, Del., May 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens JMP Life Sciences Conference, taking place in New York City on May 13 a...